Sign in
4

Changes in Ownership

Evommune, Inc. Filed Acc 0002092017-26-000005

Chief Scientific Officer sold 16,687 shares at $22.74 ($379,462)

  • Chief Scientific Officer acquired 13,512 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Patel Jeegar Pravinkumar Chief Scientific Officer 2026-06-01 Option exercise 10b5-1 +13,512 $3.84 $51,886 63,090 D: show line 1 in the form
Patel Jeegar Pravinkumar Chief Scientific Officer 2026-06-01 Sale 10b5-1 −16,687 $22.74 $379,462 46,403 D: show line 2 in the form
Open-market sales · 16,687 sh · avg $22.74 · $379,462

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Patel Jeegar Pravinkumar Chief Scientific Officer 2026-06-01 Option exercise · Employee Stock Option (Right to Buy) 10b5-1 −13,512 29,330 D: show line 3 in the form
Loading xslF345X06/primarydocument.xml…